Topoisomerase II alpha and TLE3 as predictive markers of response to anthracycline and taxane-containing regimens for neoadjuvant chemotherapy in breast cancer

PURPOSE: Anthracyclines and taxanes are considered the standard for neoadjuvant chemotherapy of breast cancer, although they are often associated with serious side effects and wide variability of individual response. In this study, we analyzed the value of topoisomerase II alpha (TOP2A) and transduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Susini, Tommaso, Berti, Barbara, Carriero, Carlo, Tavella, Ketty, Nori, Jacopo, Vanzi, Ermanno, Molino, Cecilia, Di Tommaso, Mariarosaria, Santini, Marco, Saladino, Valeria, Bianchi, Simonetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240193/
https://www.ncbi.nlm.nih.gov/pubmed/25484594
http://dx.doi.org/10.2147/OTT.S71646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240193/
https://www.ncbi.nlm.nih.gov/pubmed/25484594
http://dx.doi.org/10.2147/OTT.S71646

Ejemplares similares